Aspirin Versus Blood Thinners in Atrial Fibrillation Patients with Stroke Risk

Nearly 40 percent of patients treated with aspirin alone despite previous data showing blood thinners more beneficial —

Researchers at University of California San Diego School of Medicine and University of California, San Francisco School of Medicine report that more than 1 in 3 atrial fibrillation (AF) patients at intermediate to high risk for stroke are treated with aspirin alone, despite previous data showing this therapy to be inferior to blood thinners.

The findings publish online June 20 in the Journal of the American College of Cardiology. … Read the Full Story from the UC San Diego Newsroom


Dr. Jonathan C. Hsu

Dr. Jonathan Hsu.

The lead author of the study report is Jonathan C. Hsu, MD, MAS, Health Sciences Assistant Clinical Professor in the Cardiac Electrophysiology Section of the Division of Cardiovascular Medicine.

Read the study abstract

Atrial Fibrillation Patients at Highest Stroke Risk Not Prescribed Necessary Medication

Researcher describes findings as major gap in treatment and “wake-up call” —

Nearly half of all atrial fibrillation (AF) patients at the highest risk for stroke are not being prescribed blood thinners by their cardiologists, according to a new study by researchers at University of California, San Diego School of Medicine and University of California, San Francisco.

The study was published online March 16, 2016 in JAMA Cardiology. … Read the Full Story from the UC San Diego Newsroom


Jonathan Hsu, MD, MAS

Jonathan Hsu, MD, MAS

Jonathan C. Hsu, MD, MAS, is lead author of the study report. Dr. Hsu is Assistant Clinical Professor of Medicine in the Division of Cardiovascular Medicine.

Cardiac electrophysiology is Dr. Hsu’s primary clinical interest.

Some Atrial Fibrillation Patients Receive Unnecessary Blood Thinners

Researchers believe cardiology specialists may be unaware of risk —

About one quarter of all atrial fibrillation patients at the lowest risk for stroke receive unnecessary blood thinners from cardiology specialists, according to a new study by researchers at University of California, San Diego School of Medicine and University of California, San Francisco, and these health care providers must be made aware of the resulting potential health risks. The findings are published online April 13 by JAMA Internal Medicine.

“Clinicians who prescribe blood thinners need to be diligent about weighing the risks and benefits of these medications,” said lead author Jonathan C. Hsu, MD, cardiologist and assistant clinical professor of medicine at UC San Diego … Read the full story from the UC San Diego Newsroom


Dr. Jonathan C. Hsu

Dr. Jonathan C. Hsu

The lead author of the study report is Jonathan C. Hsu, MD, MAS, assistant clinical professor in the Division of Cardiovascular Medicine.
See Full Text of Article (PDF) (UCSD only)